Teerapong Yata

Title: Teerapong Yata: Innovator in Gene Therapy Technologies

Introduction

Teerapong Yata is a notable inventor based in London, GB, recognized for his contributions to the field of gene therapy. With a total of four patents to his name, Yata has made significant strides in developing innovative technologies that enhance the delivery of transgenes.

Latest Patents

One of Yata's latest inventions is the phagemid vector, which provides hybrid and recombinant phagemid vectors for expressing a transgene in target cells. This invention features a recombinant phagemid particle that comprises at least one transgene expression cassette, encoding an agent that exerts a biological effect on the target cell. Notably, the phagemid particle's genome lacks at least 50% of its bacteriophage genome. The invention is applicable as a research tool and for delivering transgenes in various gene therapy applications, including DNA and peptide vaccine delivery and imaging techniques. Furthermore, it extends to methods for producing viral vectors, such as recombinant adeno-associated viruses (rAAV) and lentivirus vectors (rLV), along with the genetic constructs used in these methods.

Career Highlights

Teerapong Yata is currently associated with Imperial College Innovations Limited, where he continues to push the boundaries of innovation in biotechnology. His work has garnered attention for its potential impact on medical research and therapeutic applications.

Collaborations

Yata collaborates with esteemed colleagues, including Amin Hajitou and Paladd Asavarut, contributing to a dynamic research environment that fosters innovation and development in gene therapy technologies.

Conclusion

Teerapong Yata's inventive work in gene therapy, particularly through his phagemid vector technology, showcases his commitment to advancing medical science. His contributions are poised to make a lasting impact on the field of biotechnology and therapeutic applications.